This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 May;40(5):623-625.

doi: 10.1038/s41587-022-01326-x.

Base editing marches on the clinic

Michael Eisenstein¹

Affiliations

PMID: 35534557
DOI: 10.1038/s41587-022-01326-x

Base editing marches on the clinic

Michael Eisenstein. Nat Biotechnol. 2022 May.

. 2022 May;40(5):623-625.

doi: 10.1038/s41587-022-01326-x.

Author

Michael Eisenstein¹

Affiliation

¹ , Philadelphia, PA, USA.

PMID: 35534557
DOI: 10.1038/s41587-022-01326-x

No abstract available

PubMed Disclaimer

Similar articles

Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W, Kantor B. Dong W, et al. Viruses. 2021 Jul 1;13(7):1288. doi: 10.3390/v13071288. Viruses. 2021. PMID: 34372494 Free PMC article. Review.
Recent advances in CRISPR technologies for genome editing.
Song M, Koo T. Song M, et al. Arch Pharm Res. 2021 Jun;44(6):537-552. doi: 10.1007/s12272-021-01336-4. Epub 2021 Jun 23. Arch Pharm Res. 2021. PMID: 34164771 Review.
Targeted Base Editing Systems Are Available for Plants.
Marzec M, Hensel G. Marzec M, et al. Trends Plant Sci. 2018 Nov;23(11):955-957. doi: 10.1016/j.tplants.2018.08.011. Epub 2018 Sep 14. Trends Plant Sci. 2018. PMID: 30224156
[CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
Yu C, Mo J, Zhao X, Li G, Zhang X. Yu C, et al. Sheng Wu Gong Cheng Xue Bao. 2021 Sep 25;37(9):3071-3087. doi: 10.13345/j.cjb.200693. Sheng Wu Gong Cheng Xue Bao. 2021. PMID: 34622618 Review. Chinese.
Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System.
Saw PE, Cui GH, Xu X. Saw PE, et al. ChemMedChem. 2022 May 4;17(9):e202100777. doi: 10.1002/cmdc.202100777. Epub 2022 Mar 25. ChemMedChem. 2022. PMID: 35261159 Review.

See all similar articles

Cited by

Gene editing for cardiomyopathy takes a step forward.
Giacca M. Giacca M. Cardiovasc Res. 2022 Dec 9;118(15):3011-3012. doi: 10.1093/cvr/cvac164. Cardiovasc Res. 2022. PMID: 36223597 Free PMC article. No abstract available.
Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease.
Choi DE, Shin JW, Zeng S, Hong EP, Jang JH, Loupe JM, Wheeler VC, Stutzman HE, Kleinstiver B, Lee JM. Choi DE, et al. Elife. 2024 Jun 13;12:RP89782. doi: 10.7554/eLife.89782. Elife. 2024. PMID: 38869243 Free PMC article.
Phage-assisted evolution of highly active cytosine base editors with enhanced selectivity and minimal sequence context preference.
Zhang E, Neugebauer ME, Krasnow NA, Liu DR. Zhang E, et al. Nat Commun. 2024 Feb 24;15(1):1697. doi: 10.1038/s41467-024-45969-7. Nat Commun. 2024. PMID: 38402281 Free PMC article.
De novo PAM generation to reach initially inaccessible target sites for base editing.
Pakari K, Wittbrodt J, Thumberger T. Pakari K, et al. Development. 2023 Jan 15;150(2):dev201115. doi: 10.1242/dev.201115. Epub 2023 Jan 23. Development. 2023. PMID: 36683434 Free PMC article.
Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity.
Neugebauer ME, Hsu A, Arbab M, Krasnow NA, McElroy AN, Pandey S, Doman JL, Huang TP, Raguram A, Banskota S, Newby GA, Tolar J, Osborn MJ, Liu DR. Neugebauer ME, et al. Nat Biotechnol. 2023 May;41(5):673-685. doi: 10.1038/s41587-022-01533-6. Epub 2022 Nov 10. Nat Biotechnol. 2023. PMID: 36357719 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database